Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.

Analyst Ratings

Deep Dive Into Vir Biotechnology Stock: Analyst Perspectives (6 Ratings)

By Benzinga Insights

May 7, 9:00 AM

Across the recent three months, 6 analysts have shared their insights on Vir Biotechnology (NASDAQ:VIR), expressing a variety…

VIR

News

Frontier Communications Set To Replace Hain Celestial Group In S&P MidCap 400, Hain Celestial Group To Replace Hanger In S&P SmallCap 600

By Michael Horton

September 27, 5:21 PM

Frontier Communications Parent Inc. (NASD: FYBR) will replace The Hain Celestial Group Inc. (NASD:HAIN) in the S&P Midcap 400 and The Hain Celestial Group will replace Hanger Inc. (NYSE:HNGR) in the S&P SmallCap

FYBR

Watching Allegro MicroSystems; Bear Cave Out With Short Report On Co. Titled “Problems At Allegro MicroSystems (ALGM)”

By Happy Mohamed

May 18, 10:32 AM

https://thebearcave.substack.com/p/problems-at-allegro-microsystems

ALGM

UBS Maintains Neutral on Boston Properties, Lowers Price Target to $98

By Benzinga Newsdesk

July 28, 9:35 AM

UBS analyst Michael Goldsmith maintains Boston Properties (NYSE:BXP) with a Neutral and lowers the price target from $131 to $98.

BXP

Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Related Posts

Deep Dive Into Vir Biotechnology Stock: Analyst Perspectives (6 Ratings)

Frontier Communications Set To Replace Hain Celestial Group In S&P MidCap 400, Hain Celestial Group To Replace Hanger In S&P SmallCap 600

Watching Allegro MicroSystems; Bear Cave Out With Short Report On Co. Titled “Problems At Allegro MicroSystems (ALGM)”

UBS Maintains Neutral on Boston Properties, Lowers Price Target to $98